Showing results (401-410 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|June 28, 2016
The potential of genetically guided treatment in Behçet's diseaseTamer A Gheita, Heba A Gheita, Sanaa A Kenawy
Pharmacogenomics|June 28, 2016
Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expressionMarcelo R Luizon, Mayara Caldeira-Dias, Elenice Deffune, et al.
Pharmacogenomics|October 3, 2015
Pharmacogenomics in the treatment of lung cancer: an updateDaniela Morales-Espinosa, Silvia García-Román, Niki Karachaliou, et al.
Pharmacogenomics|December 17, 2015
CYP2A6 genotyping methods and strategies using real-time and end point PCR platformsCatherine A Wassenaar, Qian Zhou, Rachel F Tyndale
Pharmacogenomics|December 1, 2015
Significant effect of VEGFA polymorphisms on the clinical outcome of metastatic colorectal cancer patients treated with FOLFIRI-cetuximabJérôme Rollin, Audrey Payancé, Valérie Gouilleux-Gruart, et al.
Pharmacogenomics|December 15, 2015
Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patientsPatricia Moya, Juliana Salazar, María Jesús Arranz, et al.
Pharmacogenomics|December 15, 2015
The pharmacogenetics of opioid therapy in the management of postpartum pain: a systematic reviewMarta Baber, Priya Bapat, Gail Nichol, et al.
Pharmacogenomics|November 3, 2017
Genotype-based tacrolimus dosing guidelines: with or without CYP3A4*22?Laure Elens, Vincent Haufroid
Pharmacogenomics|December 7, 2017
DNA variants in DHFR gene and response to treatment in children with childhood B ALL: revisited in AIEOP-BFM protocolFrancesco Ceppi, Vincent Gagné, Laurance Douyon, et al.
Pharmacogenomics|December 5, 2017
Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatmentClaudia Pisanu, Theodora Katsila, George P Patrinos, et al.
Pageof 276